Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTAW) Income from Continuing Operations (2019 - 2025)

Historic Income from Continuing Operations for Strata Critical Medical (SRTAW) over the last 7 years, with Q3 2025 value amounting to -$9.7 million.

  • Strata Critical Medical's Income from Continuing Operations fell 7161.9% to -$9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.5 million, marking a year-over-year increase of 3566.06%. This contributed to the annual value of -$27.3 million for FY2024, which is 5130.36% up from last year.
  • As of Q3 2025, Strata Critical Medical's Income from Continuing Operations stood at -$9.7 million, which was down 7161.9% from -$3.7 million recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Income from Continuing Operations ranged from a high of $8.4 million in Q2 2022 and a low of -$33.9 million during Q4 2023
  • Its 5-year average for Income from Continuing Operations is -$8.3 million, with a median of -$9.2 million in 2021.
  • As far as peak fluctuations go, Strata Critical Medical's Income from Continuing Operations plummeted by 12980638.58% in 2021, and later soared by 20824.86% in 2022.
  • Quarter analysis of 5 years shows Strata Critical Medical's Income from Continuing Operations stood at $772000.0 in 2021, then crashed by 2096.76% to -$15.4 million in 2022, then plummeted by 120.18% to -$33.9 million in 2023, then surged by 45.27% to -$18.6 million in 2024, then surged by 48.01% to -$9.7 million in 2025.
  • Its last three reported values are -$9.7 million in Q3 2025, -$3.7 million for Q2 2025, and -$3.5 million during Q1 2025.